Newton D J, Davies J, Belch J J F, Khan F
Vascular and Inflammatory Diseases Research Unit, The Institute of Cardiovascular Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Int Angiol. 2013 Jun;32(3):312-8.
Acetylcholine (ACh) is an endothelium-dependent vasodilator used to investigate endothelial function in the microcirculation. The mediators of its vasodilatory effects are not clear, but endothelium-derived hyperpolarising factor (EDHF) is thought to contribute, and appears to have particular importance in smaller peripheral vessels. The aim of this study was to investigate the role of EDHF in ACh-mediated vasodilator responses in human forearm skin.
Laser Doppler imaging was used to measure forearm skin blood flow responses to iontophoretic administration of ACh in 7 healthy men. ACh in a 10-mg/mL solution was administered in accumulating doses using increasing delivery currents of 10, 15, 20, 50 and 100 µA. The measurements were repeated on subsequent visits when the effects of EDHF were blocked using intra-arterial sulphaphenazole at 2 mg/min (a cytochrome P-450 inhibitor), nitric oxide (NO) was blocked using intra-arterial administration of the NO synthetase inhibitor l-NG-monomethyl arginine (l-NMMA) at 4 µmol/min, and prostanoids were blocked with oral aspirin 1 g.
The microvascular response to ACh was significantly attenuated by sulphaphenazole alone (P=0.018), l-NMMA alone (P<0.001) and the combination of sulphaphenazole plus l-NMMA (P<0.001), and aspirin had no additional effect.
EDHF is a significant contributor to the vasodilatory effects of ACh in the human dermal microcirculation. Information about abnormalities in specific pathways of endothelial function in patient groups may help in the targeting of appropriate drug therapies.
乙酰胆碱(ACh)是一种内皮依赖性血管舒张剂,用于研究微循环中的内皮功能。其血管舒张作用的介质尚不清楚,但内皮衍生超极化因子(EDHF)被认为起作用,并且在较小的外周血管中似乎特别重要。本研究的目的是探讨EDHF在人前臂皮肤中ACh介导的血管舒张反应中的作用。
使用激光多普勒成像测量7名健康男性前臂皮肤对离子导入给予ACh的血流反应。使用10、15、20、50和100μA递增的输送电流,以累积剂量给予10mg/mL溶液的ACh。在随后的访视中重复测量,此时使用2mg/min的动脉内磺胺苯吡唑(一种细胞色素P-450抑制剂)阻断EDHF的作用,使用4μmol/min的一氧化氮合酶抑制剂L-NG-单甲基精氨酸(L-NMMA)动脉内给药阻断一氧化氮(NO),并用1g口服阿司匹林阻断前列腺素。
单独使用磺胺苯吡唑(P=0.018)、单独使用L-NMMA(P<0.001)以及磺胺苯吡唑加L-NMMA的组合(P<0.001)均使对ACh的微血管反应显著减弱,阿司匹林无额外作用。
EDHF是ACh在人真皮微循环中血管舒张作用的重要贡献者。有关患者组内皮功能特定途径异常的信息可能有助于靶向适当的药物治疗。